Nayef A Abouzaki1,2, Jose E Exaire1,2, Luis A Guzmán3. 1. Division of Cardiology, Medical College of Virginia/VCU School of Medicine, Virginia Commonwealth University, 1200 East Broad St, 5th Floor-West wing, Room #526, Richmond, VA, 23298, USA. 2. Hunter Holmes McGuire Richmond VA Medical Center, Richmond, VA, 23249, USA. 3. Division of Cardiology, Medical College of Virginia/VCU School of Medicine, Virginia Commonwealth University, 1200 East Broad St, 5th Floor-West wing, Room #526, Richmond, VA, 23298, USA. Luis.Guzman@vcuhealth.org.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to examine current evidence on the benefit of chronic total occlusion (CTO) revascularization in patients with ischemic cardiomyopathy and propose a systematic approach on how and when to accomplish revascularization in these patients. RECENT FINDINGS: Coronary revascularization in patients with reduced ejection fraction (EF) is advocated for to improve left ventricular function and consequently clinical outcomes. Approximately 16-31% of angiograms in patients with advanced CAD are noted to have a concomitant coronary CTO. Its presence is a main predictor of worse outcomes. Over the past 15 years, advancements in interventional technologies and techniques have made it possible to treat CTO lesions percutaneously with success rates exceeding 90%. Different revascularization techniques have been organized into widely used algorithms for systematic CTO lesion crossing and treatment. Patients with reduced EF can be revascularized percutaneously with goal of complete functional revascularization. However, randomized prospective data is needed to justify the increased patient risks and healthcare costs associated with these procedures.
PURPOSE OF REVIEW: The purpose of this review is to examine current evidence on the benefit of chronic total occlusion (CTO) revascularization in patients with ischemic cardiomyopathy and propose a systematic approach on how and when to accomplish revascularization in these patients. RECENT FINDINGS: Coronary revascularization in patients with reduced ejection fraction (EF) is advocated for to improve left ventricular function and consequently clinical outcomes. Approximately 16-31% of angiograms in patients with advanced CAD are noted to have a concomitant coronary CTO. Its presence is a main predictor of worse outcomes. Over the past 15 years, advancements in interventional technologies and techniques have made it possible to treat CTO lesions percutaneously with success rates exceeding 90%. Different revascularization techniques have been organized into widely used algorithms for systematic CTO lesion crossing and treatment. Patients with reduced EF can be revascularized percutaneously with goal of complete functional revascularization. However, randomized prospective data is needed to justify the increased patient risks and healthcare costs associated with these procedures.
Entities:
Keywords:
Chronic total occlusion; Ischemic cardiomyopathy; Percutaneous intervention
Authors: Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Henry H Ting; Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Ralph G Brindis; Donald E Casey; Mina K Chung; James A de Lemos; Deborah B Diercks; James C Fang; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao Journal: J Am Coll Cardiol Date: 2015-10-21 Impact factor: 24.094
Authors: Ankur Gupta; Larry A Allen; Deepak L Bhatt; Margueritte Cox; Adam D DeVore; Paul A Heidenreich; Adrian F Hernandez; Eric D Peterson; Roland A Matsouaka; Clyde W Yancy; Gregg C Fonarow Journal: JAMA Cardiol Date: 2018-01-01 Impact factor: 14.676
Authors: Luis Nombela-Franco; Mario Iannaccone; Ignasi Anguera; Ignacio J Amat-Santos; Manuel Sanchez-Garcia; Daniel Bautista; Martin N Calvelo; Andrea Di Marco; Claudio Moretti; Roberto Pozzi; Marco Scaglione; Victoria Cañadas; María Sandin-Fuentes; Angel Arenal; Rodrigo Bagur; Nicasio Perez-Castellano; Cristina Fernandez-Perez; Fiorenzo Gaita; Carlos Macaya; Javier Escaned; Ignacio Fernández-Lozano Journal: JACC Cardiovasc Interv Date: 2017-05-08 Impact factor: 11.195
Authors: Bimmer E P M Claessen; René J van der Schaaf; Niels J Verouden; Nienke K Stegenga; Annemarie E Engstrom; Krischan D Sjauw; Wouter J Kikkert; Marije M Vis; Jan Baan; Karel T Koch; Robbert J de Winter; Jan G P Tijssen; Jan J Piek; José P S Henriques Journal: JACC Cardiovasc Interv Date: 2009-11 Impact factor: 11.195
Authors: Alfredo R Galassi; Marouane Boukhris; Aurel Toma; Zied Ibn Elhadj; Lobna Laroussi; Oliver Gaemperli; Michael Behnes; Ibrahim Akin; Thomas F Lüscher; Franz J Neumann; Kambis Mashayekhi Journal: JACC Cardiovasc Interv Date: 2017-10-18 Impact factor: 11.195
Authors: E L Alderman; L D Fisher; P Litwin; G C Kaiser; W O Myers; C Maynard; F Levine; M Schloss Journal: Circulation Date: 1983-10 Impact factor: 29.690
Authors: Eric J Velazquez; Kerry L Lee; Robert H Jones; Hussein R Al-Khalidi; James A Hill; Julio A Panza; Robert E Michler; Robert O Bonow; Torsten Doenst; Mark C Petrie; Jae K Oh; Lilin She; Vanessa L Moore; Patrice Desvigne-Nickens; George Sopko; Jean L Rouleau Journal: N Engl J Med Date: 2016-04-03 Impact factor: 91.245